CRISPR THERAPEUTICS - Trademark Details
Status: 700 - Registered
Serial Number
87872234
Registration Number
6055219
Word Mark
CRISPR THERAPEUTICS
Status
700 - Registered
Status Date
2020-05-12
Filing Date
2018-04-11
Registration Number
6055219
Registration Date
2020-05-12
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
O30
Employee Name
SCHIMPF, TIMOTHY O
Statements
Goods and Services
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; reagents for scientific and research use; kits primarily composed of reagents for scientific and research use; laboratory apparatus and instruments for preparing and processing genetic materials in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; gene editing; research and development of therapeutics using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting therapies to individuals; providing education in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Goods and Services
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Goods and Services
(Based on Use in Commerce) Education services, namely, providing publications and informational material available online in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Goods and Services
(Based on Use in Commerce) Gene editing for developing cells and pharmaceuticals for medical and clinical use; gene editing for developing cells and pharmaceuticals for scientific and research use; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting therapies to individuals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Primary Code
005
First Use Anywhere Date
2019-07-22
First Use In Commerce Date
2019-07-22
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Tiffany D. Gehrke
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Child | 87980024 |
Trademark Events
| Event Date | Event Description |
| 2018-04-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-07-31 | ASSIGNED TO EXAMINER |
| 2018-08-07 | NON-FINAL ACTION WRITTEN |
| 2018-08-07 | NON-FINAL ACTION E-MAILED |
| 2018-08-07 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-02-07 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2019-02-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-02-12 | ASSIGNED TO LIE |
| 2019-02-13 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-02-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-02-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-02-07 | DIVISIONAL REQUEST RECEIVED |
| 2019-02-21 | DIVISIONAL PROCESSING COMPLETE |
| 2019-03-13 | NON-FINAL ACTION WRITTEN |
| 2019-03-13 | NON-FINAL ACTION E-MAILED |
| 2019-03-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-04-26 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2019-04-26 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2019-09-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-09-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-09-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-09-27 | FINAL REFUSAL WRITTEN |
| 2019-09-27 | FINAL REFUSAL E-MAILED |
| 2019-09-27 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2020-03-25 | EXPARTE APPEAL RECEIVED AT TTAB |
| 2020-03-25 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 2020-03-25 | EX PARTE APPEAL-INSTITUTED |
| 2020-03-25 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2020-03-25 | TEAS AMENDMENT OF USE RECEIVED |
| 2020-03-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-03-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-03-26 | USE AMENDMENT FILED |
| 2020-03-26 | AMENDMENT TO USE PROCESSING COMPLETE |
| 2020-04-01 | USE AMENDMENT ACCEPTED |
| 2020-04-01 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| 2020-04-01 | EXPARTE APPEAL TERMINATED |
| 2020-04-02 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 2020-04-09 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2020-05-12 | REGISTERED-SUPPLEMENTAL REGISTER |
| 2020-08-05 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-08-05 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-08-05 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-08-05 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 2020-08-05 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-08-05 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-08-07 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-08-07 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-08-07 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 2020-08-07 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-04-28 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-04-28 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-04-28 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-04-28 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-04-28 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
